ARDS activates an innate immune response pathway through pathogen-associated molecular patterns (PAMPs) receptors, such as toll-like receptor 4 (TLR4), which recognizes common pathogens and triggers an immune response. This evidence concerns the gene TLR4 and acute respiratory distress syndrome.